Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain limited with resistance development by cancer cells and off-target events being major roadblocks for current therapies. The discovery of new drug molecules remains time-consuming, expensive, and prone to fail...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vineela Parvathaneni, Nishant S. Kulkarni, Snehal K. Shukla, Pamela T. Farrales, Nitesh K. Kunda, Aaron Muth, Vivek Gupta
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-02-01
Colecção:Pharmaceutics
Assuntos:
repurposing
non-small cell lung cancer
pirfenidone
liposomes
3d spheroid
apoptosis
Acesso em linha:https://www.mdpi.com/1999-4923/12/3/206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados